CD44 and neoplasm: Shimono et al. found that the miR-200 family was strongly suppressed in CD44+CD24−/low lineage human breast cancer cells and normal human mammary stem cells, whereas miR-200c strongly suppressed the ability of normal mammary stem cells to form mammary ducts and tumor formation driven by human breast CSCs in vivo [76].